Who owns NEUMORA THERAPEUTICS INC.?
- Ticker: NMRA
- CUSIP Number: 640979100
Tip: Access positions for across all investors
Analyze quarterly positions in Neumora Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neumora Therapeutics stock
Who bought or sold NEUMORA THERAPEUTICS INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Softbank Group Corp | 7.6M | $75M | 0% | Jun 2024 |
|
| BlackRock | 6.2M | $82M | 100% | Sep 2024 |
|
| T. Rowe Price Investment Management | 5.2M | $69M | 2% | Sep 2024 |
|
| BlackRock | 4.6M | $45M | 367% | Jun 2024 |
|
| MIC Capital Management UK | 4.5M | $59M | 0% | Sep 2024 |
|
| ICONIQ Capital | 3.4M | $45M | 0% | Sep 2024 |
|
| Wellcome Trust Limited, as Trustee of the Wellcome Trust | 3.3M | $44M | 0% | Sep 2024 |
|
| Vanguard Group | 3.3M | $32M | 879% | Jun 2024 |
|
| Siren | 2.6M | $34M | 100% | Sep 2024 |
|
| EcoR1 Capital | 2.1M | $20M | 0% | Jun 2024 |
|
| Geode Capital Management | 2.0M | $26M | 54% | Sep 2024 |
|
| Johnson & Johnson | 1.8M | $24M | 0% | Sep 2024 |
|
| Avidity Partners Management | 1.8M | $24M | 0% | Sep 2024 |
|
| OrbiMed Advisors | 1.5M | $20M | 0% | Sep 2024 |
|
| State Street Corporation | 1.1M | $11M | 318% | Jun 2024 |
|
| Baker Bros. Advisors | 1.0M | $14M | 0% | Sep 2024 |
|
| Ikarian Capital | 800k | $11M | 100% | Sep 2024 |
|
| Rock Springs Capital Management | 760k | $7.5M | 18% | Jun 2024 |
|
| Charles Schwab Investment Management | 698k | $9.2M | 140% | Sep 2024 |
|
| Northern Trust | 682k | $9.0M | 462% | Sep 2024 |
|
| Callan Capital | 661k | $8.7M | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 626k | $8.3M | -7% | Sep 2024 |
|
| Soros Capital Management | 509k | $6.7M | -44% | Sep 2024 |
|
| Capital Research and Management Company - Division 3 | 467k | $6.2M | 100% | Sep 2024 |
|
| Saturn V Capital Management | 390k | $3.8M | 100% | Jun 2024 |
|
| Balyasny Asset Management | 380k | $3.7M | -45% | Jun 2024 |
|
| Goldman Sachs Group | 319k | $3.1M | 96% | Jun 2024 |
|
| Woodline Partners | 308k | $4.1M | 87% | Sep 2024 |
|
| Addis & Hill | 300k | $4.0M | 0% | Sep 2024 |
|
| Logos Global Management | 300k | $2.9M | -22% | Jun 2024 |
|
| Alliancebernstein | 267k | $2.6M | 100% | Jun 2024 |
|
| Auour Investments | 250k | $2.9M | 100% | Sep 2024 |
|
| HPM Partners | 243k | $3.2M | 100% | Sep 2024 |
|
| Nuveen Asset Management | 226k | $2.2M | 988% | Jun 2024 |
|
| Wexford Capital | 218k | $2.9M | 647% | Sep 2024 |
|
| Bank of New York Mellon | 216k | $2.9M | -8% | Sep 2024 |
|
| Caption Management | 202k | $2.7M | 348% | Sep 2024 |
|
| Deep Track Capital | 181k | $1.8M | -82% | Jun 2024 |
|
| Two Sigma Investments | 173k | $1.7M | 100% | Jun 2024 |
|
| Kennedy Capital Management | 169k | $1.7M | 23% | Jun 2024 |
|
| Morgan Stanley | 157k | $1.5M | 140% | Jun 2024 |
|
| TD Asset Management | 150k | $1.9M | 4% | Sep 2024 |
|
| Ensign Peak Advisors | 150k | $2.0M | 0% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 139k | $1.8M | -39% | Sep 2024 |
|
| Barclays | 129k | $1.7M | 353% | Sep 2024 |
|
| ALPS Advisors | 118k | $1.6M | 10% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 112k | $1.1M | 79% | Jun 2024 |
|
| Rhumbline Advisers | 112k | $1.5M | 8% | Sep 2024 |
|
| LMR Partners | 102k | $1.3M | 100% | Sep 2024 |
|
| Jane Street | 92k | $1.2M | 223% | Sep 2024 |
|
| Susquehanna International | 91k | $1.2M | -8% | Sep 2024 |
|
| Point72 Asset Management | 83k | $1.1M | 100% | Sep 2024 |
|
| Ieq Capital | 83k | $814k | 0% | Jun 2024 |
|
| Citadel Advisors | 78k | $1.0M | -91% | Sep 2024 |
|
| Franklin Resources | 76k | $1.2M | -14% | Sep 2024 |
|
| Citigroup | 68k | $895k | 227% | Sep 2024 |
|
| Bank of America Corporation | 67k | $884k | 11% | Sep 2024 |
|
| Alpine Partners VI | 66k | $646k | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 64k | $851k | 3% | Sep 2024 |
|
| Wells Fargo & Company | 58k | $759k | -2% | Sep 2024 |
|
| Dark Forest Capital Management | 56k | $733k | 100% | Sep 2024 |
|
| Corton Capital | 52k | $681k | 65% | Sep 2024 |
|
| MetLife Investment Advisors | 49k | $651k | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 49k | $642k | 32% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 46k | $610k | 468% | Sep 2024 |
|
| Numerai GP | 35k | $466k | 100% | Sep 2024 |
|
| Leucadia National Corporation | 33k | $320k | 100% | Jun 2024 |
|
| PDT Partners | 31k | $414k | 0% | Sep 2024 |
|
| Two Sigma Advisers | 31k | $303k | 100% | Jun 2024 |
|
| Ing Investment Management | 28k | $365k | -2% | Sep 2024 |
|
| Handelsbanken Fonder AB | 27k | $351k | 35% | Sep 2024 |
|
| Windmill Hill Asset Management | 26k | $345k | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 26k | $344k | -24% | Sep 2024 |
|
| Verition Fund Management | 26k | $253k | 17% | Jun 2024 |
|
| SG Americas Securities | 22k | $285k | -63% | Sep 2024 |
|
| Clarius | 17k | $225k | 100% | Sep 2024 |
|
| Group One Trading | 16k | $208k | 100% | Sep 2024 |
|
| SkyOak Wealt | 15k | $198k | 0% | Sep 2024 |
|
| Invesco | 14k | $184k | 3% | Sep 2024 |
|
| Ballentine Partners | 13k | $178k | 100% | Sep 2024 |
|
| Intech Investment Management | 13k | $175k | 100% | Sep 2024 |
|
| Florida State Board of Administration | 13k | $171k | 100% | Sep 2024 |
|
| Landscape Capital Management | 11k | $143k | 0% | Sep 2024 |
|
| Legacy Private Trust | 10k | $132k | 0% | Sep 2024 |
|
| Quarry | 10k | $98k | 100% | Jun 2024 |
|
| Royal Bank of Canada | 9.3k | $128k | 17% | Sep 2024 |
|
| Summit Investment Advisors | 8.2k | $109k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 6.1k | $81k | 0% | Sep 2024 |
|
| Acadian Asset Management | 4.4k | $58k | 100% | Sep 2024 |
|
| Tower Research Capital | 3.7k | $36k | 40% | Jun 2024 |
|
| Amalgamated Bank | 2.9k | $38k | 0% | Sep 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 1.2k | $16k | 585% | Sep 2024 |
|
| NISA Investment Advisors | 1.2k | $15k | 1868% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 600.00 | $7.9k | 0% | Sep 2024 |
|
| CWM | 162.00 | $2.0k | 72% | Sep 2024 |
|
| Bessemer | 120.00 | $2.0k | 100% | Sep 2024 |
|
| Rothschild Investment | 105.00 | $1.4k | 600% | Sep 2024 |
|
| SRS Capital Advisors | 91.00 | $1.2k | 0% | Sep 2024 |
|
| Sterling Capital Management | 86.00 | $1.1k | 100% | Sep 2024 |
|
| GAMMA Investing | 53.00 | $699.997500 | 231% | Sep 2024 |
|
| Ronald Blue Trust | 38.00 | $373.999800 | 100% | Sep 2024 |
|
| Covestor | 13.00 | $0 | -7% | Sep 2024 |
|
| Capital Performance Advisors | 11.00 | $144.999800 | 100% | Sep 2024 |
|
Who sold out of Neumora Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Jun 2024 | 2.8M | $28M |
| Voloridge Investment Management | Jun 2024 | 296k | $2.9M |
| Marshall Wace | Jun 2024 | 135k | $1.3M |
| Qube Research & Technologies | Mar 2024 | 18k | $251k |
| Principal Financial Group | Jun 2024 | 17k | $166k |
| Wealth Enhancement Advisory Services | Mar 2024 | 13k | $173k |
| Oxford Asset Management | Mar 2024 | 10k | $138k |
| Simplex Trading | Jun 2024 | 5.2k | $51k |